abstract |
The present invention relates to a human monoclonal antibody specific for α-toxin of Staphylococcus aureus and a hybridoma that produces the monoclonal antibody. In addition, the present invention relates to a pharmaceutical composition comprising at least one antibody or at least one nucleic acid encoding the antibody. Furthermore, the present invention relates to the use of the above monoclonal antibody for the treatment or prevention of abscess formation. [Selection figure] None |